Haemonetics Corporation (HAE)

Haemonetics Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 22, 2026	Mar 29, 2025	Mar 30, 2024	Apr 1, 2023	Apr 2, 2022	Apr 3, 2021
Market Capitalization	3,291	3,175	4,335	4,175	3,263	5,694
Market Cap Growth	-18.15%	-26.76%	3.83%	27.92%	-42.69%	12.14%
Enterprise Value	4,252	4,145	5,011	4,717	3,809	5,827
Last Close Price	70.11	63.19	85.35	82.75	63.85	112.04
PE Ratio	20.46	18.93	36.87	36.17	75.24	71.65
Forward PE	13.75	13.21	20.49	25.45	23.82	33.88
PS Ratio	2.58	2.33	3.31	3.57	3.29	6.54
PB Ratio	3.86	3.87	4.51	5.10	4.36	7.78
P/TBV Ratio	-	-	-	54.93	-	-
P/FCF Ratio	12.98	22.29	30.18	51.08	43.08	79.34
P/OCF Ratio	11.50	17.47	23.85	15.29	18.95	52.33
PEG Ratio	1.19	1.00	1.39	2.42	1.36	2.46
EV/Sales Ratio	3.20	3.05	3.83	4.04	3.84	6.69
EV/EBITDA Ratio	11.80	11.65	16.96	18.72	19.87	31.60
EV/EBIT Ratio	16.82	16.78	24.23	28.21	36.22	58.21
EV/FCF Ratio	16.61	29.10	34.89	57.71	50.28	81.19
Debt / Equity Ratio	1.44	1.56	0.91	1.02	1.12	1.08
Debt / EBITDA Ratio	3.40	3.49	2.86	3.28	4.14	4.02
Debt / FCF Ratio	4.78	9.01	6.08	10.16	11.07	10.98
Asset Turnover	0.54	0.59	0.63	0.62	0.54	0.56
Inventory Turnover	1.50	1.71	2.07	1.98	1.50	1.49
Quick Ratio	0.92	0.88	1.29	1.85	0.95	1.26
Current Ratio	1.64	1.62	2.56	3.06	1.71	2.74
Return on Equity (ROE)	19.47%	18.83%	13.22%	14.72%	5.86%	12.05%
Return on Assets (ROA)	6.36%	6.65%	6.26%	5.51%	3.57%	4.05%
Return on Invested Capital (ROIC)	10.91%	11.33%	10.62%	10.14%	5.40%	8.96%
Return on Capital Employed (ROCE)	13.30%	13.20%	10.90%	9.90%	7.40%	6.40%
Earnings Yield	5.06%	5.28%	2.71%	2.76%	1.33%	1.40%
FCF Yield	7.70%	4.49%	3.31%	1.96%	2.32%	1.26%
Buyback Yield / Dilution	4.63%	1.30%	0.04%	-0.13%	-0.12%	1.01%

Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q